Stools
PreclinicalBiologic
Stools is one of 50 biologic programs targeting Clostridium Difficile Infection. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
49
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
317 competitors in COVID-19
#DrugCompanyPhaseTrials
1Nitrostat
VViatris Specialty LLC
Preclinical
Low-Molecular-Weight Heparin
Daiichi SankyoPreclinical
Glucocorticoid
AbbViePreclinical
Statins
SanofiPreclinical
Singulair
AstraZenecaPreclinical
Rayaldee
OOrganon and Co
Preclinical
SARS-COV-2 VACCINE
ModernaPreclinical
Biological Data
UUniversity Hospital, Bordeaux
Preclinical
Blood Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Biological Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Stools. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- VVersailles Hospital